Department of Neuropathology,
Institute of Pathology,
Department of Neuropathology, Institute of Pathology
Camelia M. Monoranu has not added Biography.
If you are Camelia M. Monoranu and would like to personalize this page please email our Author Liaison for assistance.
Correlation between 6q25.3 deletion status and survival in pediatric intracranial ependymomas.
Cancer genetics and cytogenetics Apr, 2008 | Pubmed ID: 18328946
Neuron-specific mitochondrial DNA deletion levels in sporadic Alzheimer's disease.
Current Alzheimer research Dec, 2013 | Pubmed ID: 24156256
Comparison of the amino acid tracers 18F-FET and 18F-DOPA in high-grade glioma patients.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine Oct, 2014 | Pubmed ID: 25125481
(68)Ga-Pentixafor-PET/CT for Imaging of Chemokine Receptor 4 Expression in Glioblastoma.
Theranostics , 2016 | Pubmed ID: 26909116
Cerebral amyloidoma is characterized by B-cell clonality and a stable clinical course.
Brain pathology (Zurich, Switzerland) Mar, 2018 | Pubmed ID: 28160367
CXCR4: A new player in vestibular schwannoma pathogenesis.
Oncotarget Feb, 2018 | Pubmed ID: 29515781
Prognostic Value of O-(2-[F]Fluoroethyl)-L-Tyrosine PET/CT in Newly Diagnosed WHO 2016 Grade II and III Glioma.
Molecular imaging and biology Dec, 2019 | Pubmed ID: 30977078
Circulating MACC1 Transcripts in Glioblastoma Patients Predict Prognosis and Treatment Response.
Cancers Jun, 2019 | Pubmed ID: 31200581
[Ga]-Pentixafor PET/CT for CXCR4-Mediated Imaging of Vestibular Schwannomas.
Frontiers in oncology , 2019 | Pubmed ID: 31245296
Clinical Utility of Different Approaches for Detection of Late Pseudoprogression in Glioblastoma With O-(2-[18F]Fluoroethyl)-L-Tyrosine PET.
Clinical nuclear medicine Sep, 2019 | Pubmed ID: 31274552
ADAM9: A novel player in vestibular schwannoma pathogenesis.
Oncology letters Mar, 2020 | Pubmed ID: 32194680
Analysis of ADAM9 regulation and function in vestibular schwannoma primary cells.
BMC research notes Nov, 2020 | Pubmed ID: 33176868
Protocadherin Gamma C3 (PCDHGC3) Is Strongly Expressed in Glioblastoma and Its High Expression Is Associated with Longer Progression-Free Survival of Patients.
International journal of molecular sciences Jul, 2022 | Pubmed ID: 35897674
[F]FET-PET in children and adolescents with central nervous system tumors: does it support difficult clinical decision-making?
European journal of nuclear medicine and molecular imaging May, 2023 | Pubmed ID: 36670283
Characterization and Optimization of the Tumor Microenvironment in Patient-Derived Organotypic Slices and Organoid Models of Glioblastoma.
Cancers May, 2023 | Pubmed ID: 37345035
Metastasis Associated in Colorectal Cancer 1 (MACC1) mRNA Expression Is Enhanced in Sporadic Vestibular Schwannoma and Correlates to Deafness.
Cancers Aug, 2023 | Pubmed ID: 37627117
JoVEについて
Copyright © 2023 MyJoVE Corporation. All rights reserved